P1638: EARLY USE OF ELTROMBOPAG IN ADULT PATIENTS WITH ITP WHO ARE REFRACTORY OR RELAPSED AFTER FIRST-LINE CORTICOSTEROID THERAPY – AN AD HOC ANALYSIS OF THE TAPER TRIAL RESULTS

por Ghanima, W., Zaja, F., Maier, J., Haenig, J., Lee, J., Cooper, N.
Publicado 2022

Temozolomide as salvage treatment in primary brain lymphomas

por Reni, M, Zaja, F, Mason, W, Perry, J, Mazza, E, Spina, M, Bordonaro, R, Ilariucci, F, Faedi, M, Corazzelli, G, Manno, P, Franceschi, E, Pace, A, Candela, M, Abbadessa, A, Stelitano, C, Latte, G, Ferreri, A J M
Publicado 2007

PB2307: A MULTICENTER, RANDOMIZED, OPEN-LABEL STUDY OF ROMIPLOSTIM PLUS DEXAMETHASONE VS DEXAMETHASONE IN PATIENTS WITH NEWLY DIAGNOSED PRIMARY IMMUNE THROMBOCYTOPENIA

por Mingot Castellano, M. E., Bradbury, C. A., Rosso Fernández, C., Thomas, I., Alvarez-Román, M. T., Canaro, M., Caparrós Miranda, I. S., Cappechi, M., Carpenedo, M., Evans, G., González-Lopéz, J. T., González-Porras, J. R., Jarque Ramos, I., Lozano-Almela, M. L., Lopez Fernandez, M. F., Lowe, G., Lyall, H., Pascual Izquierdo, C., Pavord, S., Rayment, R., Roberts, P., Rosique Cortina, P., Sánchez-González, B., Santoro, C., Talks, K., Valcarcel-Ferreiras, D., Zaja, F.
Publicado 2022